Spiegelman served as Senior Vice President and Chief Financial Officer of CV Therapeutics, Inc., a biopharmaceutical company that was acquired by Gilead Sciences, Inc. In ’09 2009. From 1991 to 1998, Mr. Spiegelman served at Genentech, Inc., most recently as Treasurer. Mr. Spiegelman serves on the panel of directors of Affymax also, Inc., Cyclacel Pharmaceuticals, Inc., Omeros Oncothyreon and Corporation, Inc., all publicly traded biopharmaceutical companies. Mr. Spiegelman keeps a B.A. In economics from Stanford University and an M.B.A. From the Stanford Graduate College of Business. Resource Anthera Pharmaceuticals.. Anthera Pharmaceuticals reaches agreement with the FDA on SPA for VISTA-16 clinical study Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases connected with inflammation, today that it all reached an contract with the U announced.S.Though human adults have little dark brown fat, it does have got a metabolic function evidently, like the potential to be amplified for some reason to combat obesity. In 2007, Co-workers and Spiegelman reported that they had inserted PRDM16 genes into white fats precursors, which they implanted beneath the epidermis of mice. The PRDM16 switch coaxed the white fats precursors to produce brown fat cells rather than white. To Spiegelman, this suggested the chance of transplanting PRDM16-equipped white extra fat precursors into people who are at high risk of becoming obese, to shift their metabolism slightly right into a calorie-burning mode. The new study adds another potential source of brown fat – – the muscle cell progenitors, or myoblasts, that exist in the physical body to replace mature muscle cells as required.

Other articles from category "gynecology":

Random articles